Mutations in the CNTNAP2 gene are associated with a neurodevelopmental disorder characterized by developmental delay, intellectual disability, epileptic seizures, autism spectrum disorder and behavioral abnormalities. Clinical features are variable.
The majority of patients have two pathogenic variants , while the role of a single pathogenic mutation is debated.